BD · 13 hours ago
BD 2026 Summer Internship - Quality Engineering Development Program
USA NJ - Franklin Lakes
Internship
Onsite
Intern
Start in 2026 SummerBD is one of the largest global medical technology companies in the world, seeking undergraduate students for their Quality Development Program Summer Internship. Interns will gain hands-on experience within Quality groups, collaborating with experienced Quality Engineers and cross-functional teams to contribute to meaningful projects and enhance their career readiness in the medical technology industry.
Health CareMedical DeviceTechnical Support
Responsibilities
Contribute to meaningful, results-driven projects that deliver real value across BD
Work with cross-functional teams in varied geographic and operational settings
Receive guidance from peer mentors and managers, and engage with leaders through meet & greets and lunch & learns
Qualification
Required
Completion of Junior year towards a Bachelor's degree in Biomedical Engineering, Mechanical Engineering, Life Sciences or Quality Sciences
Demonstrated technical aptitude and strong leadership potential
Ability to learn quickly, deal with ambiguity, take initiative and achieve results
Excellent written and communications skills
Proven organization and time management skills
Preferred
Prior internship or Co-op experience in Quality, Manufacturing, Engineering, or related field desired, but not required
Company
BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.
Founded in 1897
10001+ employees
H1B Sponsorship
BD has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (66)
2022 (4)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$540MKey Investors
Steris
2023-08-02Post Ipo Equity· $540M
1962-04-23IPO
Leadership Team
Tom Polen
Chairman, CEO and President
Richard Byrd
Executive Vice President and President of the BD Interventional Segment
Recent News
EIN Presswire
2026-01-09
Company data provided by crunchbase